查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405865

非侵入性产前检测市场规模、份额和趋势分析报告：按妊娠期、按妊娠风险、按方法、按技术、按产品、按应用、按最终用途、按地区、细分市场预测：2024-2030 年

Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Pregnancy Risk, By Method, By Technology, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

非侵入性产前检测市场成长与趋势：

Grand View Research, Inc的最新报告显示，到2030年，全球无创产前检测市场规模将达到81.6亿美元，2024年至2030年复合年增长率为10.06%，预计会达到这一水平。

染色体异常发生率的增加预计将加速市场成长。在所有国家中，中国每年出生人口近1,465万人，高风险怀孕数量不断增加，且无创产前筛检机会最大。

印度的遗传疾病负担也很高。根据多项研究显示，全国每166名新生儿中就有1人发现染色体异常，21三体症（唐氏症）的发生率高达800分之一，导致每年有32,000名婴儿出生时患有唐氏症。透过 NIPT 进行准确、早期的筛检可以让家庭了解婴儿的遗传问题。因此，这种高发病率预计会增加产前检测的需求。

绒毛膜绒毛取样和羊膜穿刺术等侵入性方法需要住院治疗，使患者和相关人员面临感染 COVID-19 的风险。此外，儘管对 NIPT 处方的需求不断增长，但由于大多数国家缺乏基础设施和远端医疗设施，符合资格的人数有限。

无创产前检测的报销情况差异很大。然而，政府的支持和有利的保险政策正在推动市场成长。例如，在荷兰，产前检查的费用在怀孕中期得到全额报销，导致更多人采用这些检查。印度和中国等新兴国家政府倡议鼓励生物製药产业，预计将推动对非侵入性产前检测解决方案和服务的需求。

市场上的主要参与者都专注于新产品开拓，以加强产品系列为客户提供创新产品。 2020 年 3 月，安捷伦科技推出了三款新型微阵列，以支持细胞遗传学实验室的产前和产后研究。细胞微阵列探针可高解析度检测与神经精神疾病、发育迟缓、智能障碍障碍和体质 DNA 样本中出生缺陷相关的拷贝数突变和拷贝中性杂合性缺失。

无创产前检测市场报告亮点

  • 以胎龄计算，2023 年，13 至 24 週的胎龄占据市场主导地位，因为在怀孕中期进行的非侵入性产前手术数量最多。
  • 低怀孕风险市场预计在预测期内将出现显着成长。政府的支持，例如对平均风险怀孕的预算分配，正在促进这一领域的成长。
  • 按产品划分，母体血浆中的无细胞 DNA 检测领域在 2023 年占据了最大的收益占有率。透过各种遗传分析，游离 DNA 越来越多地被用来预测产前护理中遗传疾病的风险。
  • 预计亚太地区在预测期内的复合年增长率最高。孕产妇年龄的上升和医疗保健基础设施的改善预计将加强市场成长。
  • 由于高研发投资、先进医疗设施以及全基因组定序的发展，北美在 2023 年占据市场主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素
    • 母亲平均年龄上升，染色体症候群发生率增加
    • 对早期和非侵入性胎儿检测程序的高需求
    • 改进的兑换场景
    • 增加合作和授权协议
  • 市场抑制因素分析
    • 对生殖遗传学的伦理关注
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19 影响分析

第四章 孕期经营分析

  • 非侵入性产前检测市场：妊娠期变异分析
  • 0-12週
    • 2018-2030年0-12週无创产前检测市场
  • 13-24週
    • 13-24週无创产前检测市场，2018-2030
  • 25-36週
    • 2018-2030 年 25-36 週非侵入性产前检测市场

第五章 妊娠风险业务分析

  • 非侵入性产前检测市场：妊娠风险变异分析
  • 高风险和中等风险
    • 2018-2030年高风险及中风险非侵入性产前检测市场
  • 低风险
    • 2018-2030年低风险非侵入性产前检测市场

第六章 风险业务分析方法论

  • 非侵入性产前检测市场：方法学变异分析
  • 超音波检测
    • 2018-2030年超音波检测非侵入性产前检测市场
  • 生化筛检试验
    • 筛检筛检非侵入性产前检测市场，2018-2030
  • 母体血浆检测中的游离 DNA
    • 用于母体血浆检测的无细胞DNA非侵入性产前检测市场，2018-2030年

第七章技术风险业务分析

  • 非侵入性产前检测市场：技术变革分析
  • NGS
    • NGS非侵入性产前检测市场，2018-2030年
  • 阵列技术
    • Array技术非侵入性产前检测市场，2018-2030
  • PCR
    • 2018-2030年PCR非侵入性产前检测市场
  • 其他的
    • 其他非侵入性产前检测市场，2018-2030

第八章 产品风险经营分析

  • 非侵入性产前检测市场：产品变异分析
  • 耗材和试剂
    • 2018-2030年非侵入性产前检测耗材及试剂市场
  • 装置
    • 设备无创产前检测市场，2018-2030

第 9 章应用风险的商业分析

  • 非侵入性产前检测市场：应用变化分析
  • 三体性
    • 三体无创产前检测市场，2018-2030
  • 微缺失症候群
    • 2018-2030年微缺失症候群非侵入性产前检测市场
  • 其他的
    • 其他非侵入性产前检测市场，2018-2030

第 10 章最终用途业务分析

  • 非侵入性产前检测市场：最终用途变异分析
  • 医院和诊所
    • 医院和诊所市场，2018-2030
  • 诊断实验室
    • 诊断实验室市场，2018-2030
  • 学术/研究机构
    • 学术和研究机构市场，2018-2030

第十一章区域业务分析

  • 2023年及2030年按地区分類的非侵入性产前检测市场占有率
  • 北美洲
    • 2018-2030年北美非侵入性产前检测市场
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030年欧洲无创产前检测市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区无创产前检测市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲无创产前检测市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东和非洲非侵入性产前检测市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十二章竞争形势

  • 参与企业概况
  • 财务绩效
  • 参与企业
    • 市场领导者
    • 2023年非侵入性产前检测市场占有率分析
    • 公司简介
    • 策略规划
Product Code: GVR-1-68038-310-2

Non Invasive Prenatal Testing Market Growth & Trends:

The global non invasive prenatal testing market size is expected to reach USD 8.16 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.06% from 2024 to 2030. Increasing incidence of chromosomal abnormalities is expected to accelerate market growth. Of all the countries, there is a substantial opportunity in China for non invasive prenatal screening, with nearly 14.65 million annual births and increasing number of high-risk pregnancies.

In addition, India has a heavy burden of genetic diseases. Various studies suggested that chromosomal abnormalities are found with a frequency of 1 in 166 newborns in the country, while trisomy 21 (Down syndrome) has a high incidence rate of 1 in 800 births, resulting in the birth of 32,000 newborns with Down syndrome every year. Families can benefit from accurate and early screening using NIPT to know about their baby's genetic issue. Thus, this high incidence rate is anticipated to boost the demand for prenatal tests.

With lockdowns due to COVID-19, NIPT gained attention because it delivers high accuracy screening with minimum risk of infection compared to invasive procedures like chorionic villus sampling and amniocentesis, both of which may necessitate hospitalization and put patients and medical professionals at risk of contracting COVID-19 infection. Moreover, there was increased demand for prescription of NIPTs; however, it was limited to a smaller number of eligible people due to the lack of infrastructure and adoption of telemedicine facilities in most countries.

The reimbursement scenario pertaining to non invasive prenatal testing is highly variable. However, the support from the government and favorable insurance policies boost market growth. For instance, in the Netherlands, prenatal testing expenses are fully reimbursed in the second trimester, leading to increased adoption of these tests. Increase in government initiatives to encourage the bio- and pharmaceutical industry in emerging economies such as India and China is anticipated to boost the demand for noninvasive prenatal testing solutions and services.

Key players in the market are focusing on new product development to strengthen their product portfolios and offer innovative products to customers. In March 2020, Agilent Technologies launched three new microarrays to support prenatal and postnatal research by cytogenetic laboratories. The probes on the cyto microarrays offer high-resolution detection of copy number variation and copy-neutral loss of heterozygosity related to neuropsychiatric disorders, developmental delay, intellectual disability, and congenital anomalies in constitutional DNA samples.

Non Invasive Prenatal Testing Market Report Highlights:

  • By gestation period, 13-24 weeks dominated the market in 2023 owing to the maximum number of non-invasive prenatal procedures carried out in the second trimester of the pregnancy
  • The low-risk pregnancy risk segment is expected to witness significant growth over the forecast period. Support from the government such as budget assignment for average-risk pregnancies contributed to the segment growth
  • Based on product, the cell-free DNA in maternal plasma tests segment accounted for the largest revenue share in 2023. Cell-free DNA is increasingly being utilized in predicting the risk of genetic disorders in prenatal care via various genetic analyses
  • Asia Pacific is expected to exhibit the highest CAGR over the forecast period. Rising maternal age and improving healthcare infrastructure are likely to strengthen the market growth
  • North America dominated the market in 2023 due to high R&D investments, the presence of advanced healthcare facilities, and the development of whole genome sequencing

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing average maternal age and rising incidence of chromosomal syndromes
    • 3.4.2. High demand for early and noninvasive fetal testing procedure
    • 3.4.3. Improvements in the reimbursement scenario
    • 3.4.4. Rising collaborations and licensing agreements
  • 3.5. Market Restraint Analysis
    • 3.5.1. Ethical concerns with respect to reproductive genetics
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Gestation Period Business Analysis

  • 4.1. Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis
  • 4.2. 0-12 Weeks
    • 4.2.1. 0-12 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 4.3. 13-24 Weeks
    • 4.3.1. 13-24 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 4.4. 25-36 Weeks
    • 4.4.1. 25-36 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 5. Pregnancy Risk Business Analysis

  • 5.1. Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis
  • 5.2. High & Average Risk
    • 5.2.1. High & Average Risk Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 5.3. Low Risk
    • 5.3.1. Low Risk Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Method Risk Business Analysis

  • 6.1. Non-Invasive Prenatal Testing Market: Method Movement Analysis
  • 6.2. Ultrasound Detection
    • 6.2.1. Ultrasound Detection Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 6.3. Biochemical Screening Tests
    • 6.3.1. Biochemical Screening Tests Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 6.4. Cell-free DNA in Maternal Plasma Tests
    • 6.4.1. Cell-free DNA in Maternal Plasma Tests Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 7. Technology Risk Business Analysis

  • 7.1. Non-Invasive Prenatal Testing Market: Technology Movement Analysis
  • 7.2. NGS
    • 7.2.1. NGS Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 7.3. Array Technology
    • 7.3.1. Array Technology Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 7.4. PCR
    • 7.4.1. PCR Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 8. Product Risk Business Analysis

  • 8.1. Non-Invasive Prenatal Testing Market: Product Movement Analysis
  • 8.2. Consumables & Reagents
    • 8.2.1. Consumables & Reagents Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 8.3. Instruments
    • 8.3.1. Instruments Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 9. Application Risk Business Analysis

  • 9.1. Non-Invasive Prenatal Testing Market: Application Movement Analysis
  • 9.2. TRISOMY
    • 9.2.1. TRISOMY Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 9.3. Microdeletion Syndrome
    • 9.3.1. Microdeletion Syndrome Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • 9.4. Others
    • 9.4.1. Others Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

Chapter 10. End-use Business Analysis

  • 10.1. Non-Invasive Prenatal Testing Market: End-Use Movement Analysis
  • 10.2. Hospitals & Clinics
    • 10.2.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 10.3. Diagnostics Laboratories
    • 10.3.1. Diagnostics Laboratories Companies Market, 2018 - 2030 (USD Million)
  • 10.4. Academic and Research Institutes
    • 10.4.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 11. Regional Business Analysis

  • 11.1. Non-Invasive Prenatal Testing Market Share By Region, 2023 & 2030
  • 11.2. North America
    • 11.2.1. North America Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.2.2. U.S.
      • 11.2.2.1. Key Country Dynamics
      • 11.2.2.2. Target Disease Prevalence
      • 11.2.2.3. Competitive Scenario
      • 11.2.2.4. Regulatory Framework
      • 11.2.2.5. Reimbursement Scenario
      • 11.2.2.6. U.S. Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.2.3. Canada
      • 11.2.3.1. Key Country Dynamics
      • 11.2.3.2. Target Disease Prevalence
      • 11.2.3.3. Competitive Scenario
      • 11.2.3.4. Regulatory Framework
      • 11.2.3.5. Reimbursement Scenario
      • 11.2.3.6. Canada Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.3. Europe
    • 11.3.1. Europe Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.3.2. Germany
      • 11.3.2.1. Key Country Dynamics
      • 11.3.2.2. Target Disease Prevalence
      • 11.3.2.3. Competitive Scenario
      • 11.3.2.4. Regulatory Framework
      • 11.3.2.5. Reimbursement Scenario
      • 11.3.2.6. Germany Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.3.3. UK
      • 11.3.3.1. Key Country Dynamics
      • 11.3.3.2. Target Disease Prevalence
      • 11.3.3.3. Competitive Scenario
      • 11.3.3.4. Regulatory Framework
      • 11.3.3.5. Reimbursement Scenario
      • 11.3.3.6. UK Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.3.4. France
      • 11.3.4.1. Key Country Dynamics
      • 11.3.4.2. Target Disease Prevalence
      • 11.3.4.3. Competitive Scenario
      • 11.3.4.4. Regulatory Framework
      • 11.3.4.5. Reimbursement Scenario
      • 11.3.4.6. France Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.3.5. Italy
      • 11.3.5.1. Key Country Dynamics
      • 11.3.5.2. Target Disease Prevalence
      • 11.3.5.3. Competitive Scenario
      • 11.3.5.4. Regulatory Framework
      • 11.3.5.5. Reimbursement Scenario
      • 11.3.5.6. Italy Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.3.6. Spain
      • 11.3.6.1. Key Country Dynamics
      • 11.3.6.2. Target Disease Prevalence
      • 11.3.6.3. Competitive Scenario
      • 11.3.6.4. Regulatory Framework
      • 11.3.6.5. Reimbursement Scenario
      • 11.3.6.6. Spain Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.3.7. Denmark
      • 11.3.7.1. Key Country Dynamics
      • 11.3.7.2. Target Disease Prevalence
      • 11.3.7.3. Competitive Scenario
      • 11.3.7.4. Regulatory Framework
      • 11.3.7.5. Reimbursement Scenario
      • 11.3.7.6. Denmark Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.3.8. Sweden
      • 11.3.8.1. Key Country Dynamics
      • 11.3.8.2. Target Disease Prevalence
      • 11.3.8.3. Competitive Scenario
      • 11.3.8.4. Regulatory Framework
      • 11.3.8.5. Reimbursement Scenario
      • 11.3.8.6. Sweden Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.3.9. Norway
      • 11.3.9.1. Key Country Dynamics
      • 11.3.9.2. Target Disease Prevalence
      • 11.3.9.3. Competitive Scenario
      • 11.3.9.4. Regulatory Framework
      • 11.3.9.5. Reimbursement Scenario
      • 11.3.9.6. Norway Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.4. Asia Pacific
    • 11.4.1. Asia Pacific Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.4.2. Japan
      • 11.4.2.1. Key Country Dynamics
      • 11.4.2.2. Target Disease Prevalence
      • 11.4.2.3. Competitive Scenario
      • 11.4.2.4. Regulatory Framework
      • 11.4.2.5. Reimbursement Scenario
      • 11.4.2.6. Japan Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.4.3. China
      • 11.4.3.1. Key Country Dynamics
      • 11.4.3.2. Target Disease Prevalence
      • 11.4.3.3. Competitive Scenario
      • 11.4.3.4. Regulatory Framework
      • 11.4.3.5. Reimbursement Scenario
      • 11.4.3.6. China Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.4.4. India
      • 11.4.4.1. Key Country Dynamics
      • 11.4.4.2. Target Disease Prevalence
      • 11.4.4.3. Competitive Scenario
      • 11.4.4.4. Regulatory Framework
      • 11.4.4.5. Reimbursement Scenario
      • 11.4.4.6. India Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.4.5. South Korea
      • 11.4.5.1. Key Country Dynamics
      • 11.4.5.2. Target Disease Prevalence
      • 11.4.5.3. Competitive Scenario
      • 11.4.5.4. Regulatory Framework
      • 11.4.5.5. Reimbursement Scenario
      • 11.4.5.6. South Korea Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.4.6. Australia
      • 11.4.6.1. Key Country Dynamics
      • 11.4.6.2. Target Disease Prevalence
      • 11.4.6.3. Competitive Scenario
      • 11.4.6.4. Regulatory Framework
      • 11.4.6.5. Reimbursement Scenario
      • 11.4.6.6. Australia Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.4.7. Thailand
      • 11.4.7.1. Key Country Dynamics
      • 11.4.7.2. Target Disease Prevalence
      • 11.4.7.3. Competitive Scenario
      • 11.4.7.4. Regulatory Framework
      • 11.4.7.5. Reimbursement Scenario
      • 11.4.7.6. Thailand Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.5. Latin America
    • 11.5.1. Latin America Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.5.2. Brazil
      • 11.5.2.1. Key Country Dynamics
      • 11.5.2.2. Target Disease Prevalence
      • 11.5.2.3. Competitive Scenario
      • 11.5.2.4. Regulatory Framework
      • 11.5.2.5. Reimbursement Scenario
      • 11.5.2.6. Brazil Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.5.3. Mexico
      • 11.5.3.1. Key Country Dynamics
      • 11.5.3.2. Target Disease Prevalence
      • 11.5.3.3. Competitive Scenario
      • 11.5.3.4. Regulatory Framework
      • 11.5.3.5. Reimbursement Scenario
      • 11.5.3.6. Mexico Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.5.4. Argentina
      • 11.5.4.1. Key Country Dynamics
      • 11.5.4.2. Target Disease Prevalence
      • 11.5.4.3. Competitive Scenario
      • 11.5.4.4. Regulatory Framework
      • 11.5.4.5. Reimbursement Scenario
      • 11.5.4.6. Argentina Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
  • 11.6. MEA
    • 11.6.1. MEA Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.6.2. South Africa
      • 11.6.2.1. Key Country Dynamics
      • 11.6.2.2. Target Disease Prevalence
      • 11.6.2.3. Competitive Scenario
      • 11.6.2.4. Regulatory Framework
      • 11.6.2.5. Reimbursement Scenario
      • 11.6.2.6. South Africa Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.6.3. Saudi Arabia
      • 11.6.3.1. Key Country Dynamics
      • 11.6.3.2. Target Disease Prevalence
      • 11.6.3.3. Competitive Scenario
      • 11.6.3.4. Regulatory Framework
      • 11.6.3.5. Reimbursement Scenario
      • 11.6.3.6. Saudi Arabia Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.6.4. UAE
      • 11.6.4.1. Key Country Dynamics
      • 11.6.4.2. Target Disease Prevalence
      • 11.6.4.3. Competitive Scenario
      • 11.6.4.4. Regulatory Framework
      • 11.6.4.5. Reimbursement Scenario
      • 11.6.4.6. UAE Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
    • 11.6.5. Kuwait
      • 11.6.5.1. Key Country Dynamics
      • 11.6.5.2. Target Disease Prevalence
      • 11.6.5.3. Competitive Scenario
      • 11.6.5.4. Regulatory Framework
      • 11.6.5.5. Reimbursement Scenario
      • 11.6.5.6. Kuwait Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)

Chapter 12. Competitive Landscape

  • 12.1. Participant's overview
  • 12.2. Financial performance
  • 12.3. Participant categorization
    • 12.3.1. Market Leaders
    • 12.3.2. Non-Invasive Prenatal Testing market Share Analysis, 2023
    • 12.3.3. Company Profiles
      • 12.3.3.1. Genesis Genetics (CooperSurgical, Inc.)
      • 12.3.3.1.1. Company Overview
      • 12.3.3.1.2. Financial Performance
      • 12.3.3.1.3. Product Benchmarking
      • 12.3.3.1.4. Strategic Initiatives
      • 12.3.3.2. Natera, Inc.
      • 12.3.3.2.1. Company Overview
      • 12.3.3.2.2. Financial Performance
      • 12.3.3.2.3. Product Benchmarking
      • 12.3.3.2.4. Strategic Initiatives
      • 12.3.3.3. Centogene N.V.
      • 12.3.3.3.1. Company Overview
      • 12.3.3.3.2. Financial Performance
      • 12.3.3.3.3. Product Benchmarking
      • 12.3.3.3.4. Strategic Initiatives
      • 12.3.3.4. Eurofins Scientific
      • 12.3.3.4.1. Company Overview
      • 12.3.3.4.2. Financial Performance
      • 12.3.3.4.3. Product Benchmarking
      • 12.3.3.4.4. Strategic Initiatives
      • 12.3.3.5. MedGenome Labs Ltd.
      • 12.3.3.5.1. Company Overview
      • 12.3.3.5.2. Financial Performance
      • 12.3.3.5.3. Product Benchmarking
      • 12.3.3.5.4. Strategic Initiatives
      • 12.3.3.6. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
      • 12.3.3.6.1. Company Overview
      • 12.3.3.6.2. Financial Performance
      • 12.3.3.6.3. Product Benchmarking
      • 12.3.3.6.4. Strategic Initiatives
      • 12.3.3.7. Myriad Women's Health, Inc. (Counsyl, Inc.)
      • 12.3.3.7.1. Company Overview
      • 12.3.3.7.2. Financial Performance
      • 12.3.3.7.3. Product Benchmarking
      • 12.3.3.7.4. Strategic Initiatives
      • 12.3.3.8. Progenity, Inc.
      • 12.3.3.8.1. Company Overview
      • 12.3.3.8.2. Financial Performance
      • 12.3.3.8.3. Product Benchmarking
      • 12.3.3.8.4. Strategic Initiatives
      • 12.3.3.9. Qiagen
      • 12.3.3.9.1. Company Overview
      • 12.3.3.9.2. Financial Performance
      • 12.3.3.9.3. Product Benchmarking
      • 12.3.3.9.4. Strategic Initiatives
      • 12.3.3.10. Laboratory Corp. of America Holdings
      • 12.3.3.10.1. Company Overview
      • 12.3.3.10.2. Financial Performance
      • 12.3.3.10.3. Product Benchmarking
      • 12.3.3.10.4. Strategic Initiatives
      • 12.3.3.11. Illumina, Inc. (Verinata Health, Inc.)
      • 12.3.3.11.1. Company Overview
      • 12.3.3.11.2. Financial Performance
      • 12.3.3.11.3. Product Benchmarking
      • 12.3.3.11.4. Strategic Initiatives
      • 12.3.3.12. Quest Diagnostics, Inc.
      • 12.3.3.12.1. Company Overview
      • 12.3.3.12.2. Financial Performance
      • 12.3.3.12.3. Product Benchmarking
      • 12.3.3.12.4. Strategic Initiatives
    • 12.3.4. Strategy Mapping
      • 12.3.4.1. Expansion
      • 12.3.4.2. Acquisition
      • 12.3.4.3. Collaborations
      • 12.3.4.4. Product Type/Product Launch
      • 12.3.4.5. Partnerships
      • 12.3.4.6. Others

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 Regulatory framework
  • TABLE 4 Risk of Trisomy 21 and chromosomal abnormalities with maternal age
  • TABLE 5 Average selling prices of non-invasive prenatal tests
  • TABLE 6 North America NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 7 North America NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 8 North America NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 9 North America NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 10 North America NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 11 North America NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 12 North America NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 13 North America NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 16 U.S. NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 17 U.S. NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 18 U.S. NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 19 U.S. NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 20 U.S. NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 21 Canada NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 22 Canada NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 23 Canada NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 24 Canada NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 25 Canada NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 26 Canada NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 27 Canada NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Europe NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 29 Europe NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 30 Europe NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 31 Europe NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 32 Europe NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 33 Europe NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 34 Europe NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 35 Europe NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 36 U.K. NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 37 U.K. NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 38 U.K. NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 39 U.K. NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 40 U.K. NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 41 U.K. NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 42 U.K. NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 Germany NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 44 Germany NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 45 Germany NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 46 Germany NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 47 Germany NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 48 Germany NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 49 Germany NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 50 France NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 51 France NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 52 France NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 53 France NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 54 France NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 55 France NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 56 France NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 57 Italy NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 58 Italy NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 59 Italy NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 60 Italy NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 61 Italy NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 62 Italy NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 63 Italy NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 64 Spain NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 65 Spain NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 66 Spain NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 67 Spain NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 68 Spain NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 69 Spain NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 70 Spain NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 71 Denmark NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 72 Denmark NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 73 Denmark NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 74 Denmark NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 75 Denmark NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 76 Denmark NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 77 Denmark NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 78 Sweden NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 79 Sweden NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 80 Sweden NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 81 Sweden NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 82 Sweden NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 83 Sweden NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 84 Sweden NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 85 Norway NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 86 Norway NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 87 Norway NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 88 Norway NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 89 Norway NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 90 Norway NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 91 Norway NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 92 Asia Pacific NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 93 Asia Pacific NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 94 Asia Pacific NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 95 Asia Pacific NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 96 Asia Pacific NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 97 Asia Pacific NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 98 Asia Pacific NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 99 Asia Pacific NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 100 Japan NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 101 Japan NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 102 Japan NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 103 Japan NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 104 Japan NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 105 Japan NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 106 Japan NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 107 China NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 108 China NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 109 China NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 110 China NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 111 China NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 112 China NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 113 China NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 114 India NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 115 India NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 116 India NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 117 India NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 118 India NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 119 India NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 120 India NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 121 South Korea NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 122 South Korea NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 123 South Korea NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 124 South Korea NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 125 South Korea NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 126 South Korea NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 127 South Korea NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 128 Australia NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 129 Australia NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 130 Australia NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 131 Australia NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 132 Australia NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 133 Australia NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 134 Australia NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 135 Thailand NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 136 Thailand NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 137 Thailand NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 138 Thailand NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 139 Thailand NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 140 Thailand NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 141 Thailand NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 142 Latin America NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 143 Latin America NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 144 Latin America NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 145 Latin America NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 146 Latin America NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 147 Latin America NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 148 Latin America NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 149 Latin America NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 150 Brazil NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 151 Brazil NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 152 Brazil NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 153 Brazil NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 154 Brazil NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 155 Brazil NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 156 Brazil NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 157 Mexico NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 158 Mexico NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 159 Mexico NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 160 Mexico NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 161 Mexico NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 162 Mexico NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 163 Mexico NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 164 Argentina NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 165 Argentina NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 166 Argentina NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 167 Argentina NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 168 Argentina NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 169 Argentina NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 170 Argentina NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 171 MEA NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 172 MEA NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 173 MEA NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 174 MEA NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 175 MEA NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 176 MEA NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 177 MEA NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 178 MEA NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 179 South Africa NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 180 South Africa NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 181 South Africa NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 182 South Africa NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 183 South Africa NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 184 South Africa NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 185 South Africa NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 186 Saudi Arabia NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 187 Saudi Arabia NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 188 Saudi Arabia NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 189 Saudi Arabia NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 190 Saudi Arabia NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 191 Saudi Arabia NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 192 Saudi Arabia NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 193 UAE NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 194 UAE NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 195 UAE NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 196 UAE NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 197 UAE NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 198 UAE NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 199 UAE NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 200 Kuwait NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
  • TABLE 201 Kuwait NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
  • TABLE 202 Kuwait NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • TABLE 203 Kuwait NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • TABLE 204 Kuwait NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 205 Kuwait NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 206 Kuwait NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Non-Invasive Prenatal Testing Market Segmentation
  • FIG. 8 Market Snapshot, 2023
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Global Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis
  • FIG. 15 Global Non-Invasive Prenatal Testing Market, by 0-12 Weeks, 2018 - 2030 (USD Million)
  • FIG. 16 Global Non-Invasive Prenatal Testing Market, by 13-24 Weeks, 2018 - 2030 (USD Million)
  • FIG. 17 Global Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis
  • FIG. 18 Global Non-Invasive Prenatal Testing Market, by High & Average Risk, 2018 - 2030 (USD Million)
  • FIG. 19 Global Non-Invasive Prenatal Testing Market, by Low Risk, 2018 - 2030 (USD Million)
  • FIG. 20 Global Non-Invasive Prenatal Testing Market: Method Movement Analysis
  • FIG. 21 Global Non-Invasive Prenatal Testing Market, by Ultrasound Detection, 2018 - 2030 (USD Million)
  • FIG. 22 Global Non-Invasive Prenatal Testing Market, by Biochemical Screening Tests, 2018 - 2030 (USD Million)
  • FIG. 23 Global Non-Invasive Prenatal Testing Market, by Cell-free DNA in Maternal Plasma Tests, 2018 - 2030 (USD Million)
  • FIG. 24 Global Non-Invasive Prenatal Testing Market: Technology Movement Analysis
  • FIG. 25 Global Non-Invasive Prenatal Testing Market, by NGS, 2018 - 2030 (USD Million)
  • FIG. 26 Global Non-Invasive Prenatal Testing Market, by Array Technology, 2018 - 2030 (USD Million)
  • FIG. 27 Global Non-Invasive Prenatal Testing Market, by PCR, 2018 - 2030 (USD Million)
  • FIG. 28 Global Non-Invasive Prenatal Testing Market, by Others, 2018 - 2030 (USD Million)
  • FIG. 29 Global Non-Invasive Prenatal Testing Market: Product Movement Analysis
  • FIG. 30 Global Non-Invasive Prenatal Testing Market, by Consumables & Reagents, 2018 - 2030 (USD Million)
  • FIG. 31 Global Non-Invasive Prenatal Testing Market, by Instruments, 2018 - 2030 (USD Million)
  • FIG. 32 Global Non-Invasive Prenatal Testing Market: Application Movement Analysis
  • FIG. 33 Global Non-Invasive Prenatal Testing Market, by Trisomy, 2018 - 2030 (USD Million)
  • FIG. 34 Global Non-Invasive Prenatal Testing Market, by Microdeletion Syndrome, 2018 - 2030 (USD Million)
  • FIG. 35 Global Non-Invasive Prenatal Testing Market, by Other Applications, 2018 - 2030 (USD Million)
  • FIG. 36 Global Non-Invasive Prenatal Testing Market: End-use Movement Analysis
  • FIG. 37 Global Non-Invasive Prenatal Testing Market, by Hospitals & Clinics, 2018 - 2030 (USD Million)
  • FIG. 38 Global Non-Invasive Prenatal Testing Market, by Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • FIG. 39 Regional Marketplace: Key Takeaways
  • FIG. 40 Regional Outlook, 2023 & 2030
  • FIG. 41 Global Non-Invasive Prenatal Testing Market: Region Movement Analysis
  • FIG. 42 North America Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 43 U.S. Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 44 Canada Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 45 Europe Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 46 Germany Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 47 UK Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 48 France Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 49 Italy Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 50 Spain Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 51 Denmark Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 52 Sweden Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 53 Norway Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 54 Asia Pacific Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 55 Japan Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 56 China Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 57 India Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 58 Australia Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 59 South Korea Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 60 Thailand Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 61 Latin America Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 62 Brazil Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 63 Mexico Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 64 Argentina Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 65 Middle East and Africa Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 66 South Africa Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 67 Saudi Arabia Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 68 UAE Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
  • FIG. 69 Kuwait Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)